Recent Quarter Total Invested
$4.50 M
Recent Quarter Institutional Ownership Percentage
14.22%
Total Invested of Last Quarter
$2.81 M
Ownership Percentage of Last Quarter
15.89%
Oncternal Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 03/11/2024 | 2.86 M | $1.53 M | 0.00% | 4.85% |
MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 2.06 M | $1.10 M | 24.81% | 3.49% |
BLACKROCK INC. | 02/13/2024 | 785,681 | $421,282 | 0.00% | 1.33% |
PASADENA PRIVATE WEALTH, LLC | 01/10/2024 | 500,000 | $268,100 | 79.37% | 0.85% |
RICHMOND BROTHERS, INC. | 02/08/2024 | 494,042 | $264,907 | 0.00% | 0.84% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 327,200 | $175,000 | 4.44% | 0.55% |
LPL FINANCIAL LLC | 02/14/2024 | 171,459 | $91,936 | 0.00% | 0.29% |
STATE STREET CORP | 02/14/2024 | 161,401 | $86,543 | 0.00% | 0.27% |
IEQ CAPITAL, LLC | 02/07/2024 | 144,434 | $77,446 | 0.00% | 0.25% |
MORGAN STANLEY | 08/16/2024 | 92,980 | $49,856 | -5.10% | 0.16% |
NORTHERN TRUST CORP | 02/13/2024 | 84,706 | $45,419 | 0.00% | 0.14% |
TWO SIGMA ADVISERS, LP | 02/14/2024 | 83,600 | $44,826 | -15.04% | 0.14% |
TWO SIGMA INVESTMENTS, LP | 02/14/2024 | 74,681 | $40,044 | 0.00% | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 02/13/2024 | 72,775 | $38,000 | 0.00% | 0.12% |
AXXCESS WEALTH MANAGEMENT, LLC | 02/06/2024 | 70,363 | $37,729 | 0.00% | 0.12% |
TWO SIGMA SECURITIES, LLC | 02/14/2024 | 58,761 | $31,508 | 176.86% | 0.10% |
CITADEL ADVISORS LLC | 02/14/2024 | 54,279 | $29,104 | 100.00% | 0.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 01/25/2024 | 53,554 | $28,716 | 0.00% | 0.09% |
BALBOA WEALTH PARTNERS | 02/09/2024 | 47,500 | $25,470 | 0.00% | 0.08% |
CREATIVE PLANNING | 02/14/2024 | 39,318 | $21,082 | 0.00% | 0.07% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2024 | 32,249 | $17,292 | 0.00% | 0.05% |
BETA WEALTH GROUP, INC. | 02/12/2024 | 32,000 | $17,158 | 0.00% | 0.05% |
IPG INVESTMENT ADVISORS LLC | 02/12/2024 | 23,319 | $12,504 | 100.00% | 0.04% |
JPMORGAN CHASE & CO | 02/12/2024 | 20,087 | $10,770 | 0.00% | 0.03% |
XTX TOPCO LTD | 02/13/2024 | 19,505 | $10,459 | 100.00% | 0.03% |
ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 8,850 | $4,745 | -28.92% | 0.02% |
WELLS FARGO & COMPANY/MN | 02/09/2024 | 6,417 | $3,441 | 0.33% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 4,962 | $2,660 | -74.33% | 0.01% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2024 | 3,645 | $1,954 | 0.00% | 0.01% |
UBS GROUP AG | 02/09/2024 | 2,000 | $1,072 | -85.27% | 0.00% |
TRUVESTMENTS CAPITAL LLC | 02/14/2024 | 440 | $236 | 0.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2024 | 300 | $161 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2024 | 35 | $19 | -99.42% | 0.00% |
COPPELL ADVISORY SOLUTIONS LLC | 02/14/2024 | 20 | $11 | -65.52% | 0.00% |
DELTA ASSET MANAGEMENT LLC/TN | 02/09/2024 | 7 | $4 | 0.00% | 0.00% |
CETERA TRUST COMPANY, N.A | 02/01/2024 | 7 | $4 | 100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/13/2024 | 1 | $1 | 100.00% | 0.00% |
MERCER GLOBAL ADVISORS INC /ADV | 02/15/2024 | 0 | $0 | -100.00% | 0.00% |
MACKENZIE FINANCIAL CORP | 01/30/2024 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
NORTH STAR INVESTMENT MANAGEMENT CORP. | 01/10/2024 | 0 | $0 | -100.00% | 0.00% |
BRIGHTON JONES LLC | 02/05/2024 | 0 | $0 | -100.00% | 0.00% |
AUREUS ASSET MANAGEMENT, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
BANK OF NEW YORK MELLON CORP | 01/29/2024 | 0 | $0 | -100.00% | 0.00% |
ENVESTNET ASSET MANAGEMENT INC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
BAADER BANK AKTIENGESELLSCHAFT | 02/08/2024 | 0 | $0 | -100.00% | 0.00% |
JANE STREET GROUP, LLC | 02/15/2024 | 0 | $0 | -100.00% | 0.00% |
VALEO FINANCIAL ADVISORS, LLC | 01/29/2024 | 0 | $0 | -100.00% | 0.00% |
Oncternal Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ONCT shares?
During the previous two years, 6 institutional investors and hedge funds held shares of Oncternal Therapeutics, Inc.. The most heavily invested institutionals were:
Column Capital Advisors, LLC: 1,450
ACT CAPITAL MANAGEMENT, LLC: 210,000
DOWLING & YAHNKE LLC: 150,464
Amalgamated Financial Corp.: 5,328
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 0
XTX MARKETS LLC: 10,754
-
What percentage of Oncternal Therapeutics, Inc. stock is owned by institutional investors?
14.22% of Oncternal Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ONCT ?
Institutional investors have bought a total of 377,996 shares in the last 24 months. This purchase volume represents approximately $423,356 in transactions.